Characteristics and outcomes of patients with V299L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors

Elias Jabbour, Van Morris, Hagop Kantarjian, Cameron C. Yin, Elizabeth Burton, Jorge Cortes

Research output: Contribution to journalLetter

9 Scopus citations
Original languageEnglish (US)
Pages (from-to)3382-3383
Number of pages2
JournalBlood
Volume120
Issue number16
DOIs
StatePublished - Oct 18 2012
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this